Global micro Invasive glaucoma surgery (MIGS) devices market is projected to register a CAGR of 31.7% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product (MIGS Stents, MIGS Shunts and Others), Target (Trabecular Meshwork Suprachoroidal Space Subconjunctival Filtration and Reducing Aqueous Production), Surgery Type (Glaucoma in Conjunction with Cataract and Stand-Alone Glaucoma), End User (Hospital Outpatient Departments (HOPD), Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS) and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa) Industry Trends & Forecast to 2020.

Some of the major factors contributing to the growth of the global micro invasive glaucoma surgery (MIGS) devices market are:

• Increase in the geriatric population
• Rising incidence of glaucoma across the world
• Government initiatives to increase awareness about prevention of blindness

Market Players:

The key market players for global micro invasive glaucoma surgery (MIGS) devices market are listed below:

• Glaukos Corporation
• Ivantis Inc.
• Allergan
• Ellex
• Alcon
• BVI
• Johnson and Johnson Surgical Vision Inc. and Johnson and Johnson Vision Care Inc. (A subsidiary of Johnson and Johnson Inc.)
• Microsurgical technology
• Molteno Ophthalmic Ltd.
• New world Medical
• Santen Pharmaceutical
• Sight Scientific